Takeaways: Health Canada’s approval positions GSK as a first mover in Canada’s chronic hepatitis B market with the first and only finite therapy indicated to achieve functional cure....
Browsing Tag: Phase III Clinical Trials
Takeaways: Health Canada’s approval positions GSK as a first mover in Canada’s chronic hepatitis B market with the first and only finite therapy indicated to achieve functional cure....